近日,EvaluatePharma发布《2025年全球制药行业展望》。报告显示,到2030年,全球处方药总销售额预计将增长至1.756万亿美元,届时GLP-1药物销售额将占处方药总销售额的9%。“它们自成一派”且“独领风骚”,EvaluatePharma如此评价。在全球药品销售额TOP10预测名单中,GLP-1产品占据了一半席位,包括Mounjaro(替尔泊肽)、Zepbound(替尔泊肽)、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.